Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium
- PMID: 2872839
- DOI: 10.1097/00000542-198606000-00006
Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium
Abstract
To compare the time course of neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium, the authors studied 98 patients anesthetized with nitrous oxide (60%) and halothane or enflurane. Neuromuscular blockade, as monitored by single stimulus-induced twitch tension (TT), was antagonized at varying degrees of spontaneous recovery (2-80% of control TT). Time to antagonism (time from injection of neostigmine or edrophonium to 90% recovery of control TT) was not different between edrophonium, 0.5 mg/kg, and neostigmine, 0.04 mg/kg, when spontaneous recovery had been allowed to occur to at least 11% of control TT prior to antagonist administration (P greater than 0.05). For profound neuromuscular blockade (TT less than or equal to 10% of control) induced by pancuronium or vecuronium, time (mean +/- SD) to antagonism with neostigmine, 0.04 mg/kg, was 7.0 +/- 2.2 min and 5.6 +/- 1.7 min, respectively, while the same for edrophonium, 0.5 mg/kg, was 20.0 +/- 8.0 min and 15.0 +/- 12.5 min, respectively (P less than 0.05). Time to antagonism of profound atracurium-induced neuromuscular blockade was 8.5 +/- 3.3 min for neostigmine, 0.04 mg/kg, and 9.8 +/- 7.0 min for edrophonium, 0.5 mg/kg, (P less than 0.05). For profound vecuronium-and pancuronium-induced neuromuscular blockade, time to antagonism by edrophonium, 1.0 mg/kg, was 4.6 +/- 3.0 min and 3.9 +/- 1.6 min respectively. The authors conclude that neostigmine, 0.04 mg/kg, antagonizes neuromuscular blockade within 12 min when TT is greater than 2% of control at time of reversal. When TT is greater than 10% of control, edrophonium, 0.5 mg/kg, produces similar time to antagonism.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.Anesthesiology. 1986 Dec;65(6):572-8. doi: 10.1097/00000542-198612000-00002. Anesthesiology. 1986. PMID: 2878631
-
Neostigmine and edrophonium as antagonists of atracurium and pancuronium.Acta Anaesthesiol Scand. 1988 Aug;32(6):437-40. doi: 10.1111/j.1399-6576.1988.tb02762.x. Acta Anaesthesiol Scand. 1988. PMID: 2845694 Clinical Trial.
-
Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.Anesthesiology. 1989 Jul;71(1):37-43. doi: 10.1097/00000542-198907000-00007. Anesthesiology. 1989. PMID: 2568767 Clinical Trial.
-
Spontaneous recovery or evoked reversal of neuromuscular block.Acta Anaesthesiol Scand Suppl. 1995;106:62-5. doi: 10.1111/j.1399-6576.1995.tb04313.x. Acta Anaesthesiol Scand Suppl. 1995. PMID: 8533549 Review.
-
Clinical pharmacology of vecuronium and atracurium.Anesthesiology. 1984 Oct;61(4):444-53. doi: 10.1097/00000542-198410000-00014. Anesthesiology. 1984. PMID: 6148907 Review.
Cited by
-
Priming with anti-cholinesterases--the effect of different priming doses of edrophonium.Can J Anaesth. 1988 Jan;35(1):53-7. doi: 10.1007/BF03010545. Can J Anaesth. 1988. PMID: 3349555 Clinical Trial.
-
Monitoring, new drugs, and reversal of neuromuscular blocking drugs.Can J Anaesth. 1991 May;38(4 Pt 2):R89-97. doi: 10.1007/BF03008437. Can J Anaesth. 1991. PMID: 2060078 Review. English, French. No abstract available.
-
New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.Drugs. 1987 Jul;34(1):98-135. doi: 10.2165/00003495-198734010-00004. Drugs. 1987. PMID: 3308413 Review.
-
Priming with anti-cholinesterases--the effect of different combinations of anti-cholinesterases and different priming intervals.Can J Anaesth. 1988 Jan;35(1):47-52. doi: 10.1007/BF03010544. Can J Anaesth. 1988. PMID: 3349554 Clinical Trial.
-
Neostigmine and edrophonium for reversal of pipecuronium neuromuscular blockade.Can J Anaesth. 1991 Mar;38(2):159-63. doi: 10.1007/BF03008137. Can J Anaesth. 1991. PMID: 1850665
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources